News About: Pharm. Affairs


The tobacco price increase accelerated sales of antismoking products, making rapid inclines in sales on the 1st quarter

Due to the tobacco price increase, the antismoking product market is on the highest booming cycle. On the last 1st quarter when the government support is invested, sales performance of both ETC and OTC drugs have been...

In front of the hospital closed by MERS, pharmacies will have the ‘payment crisis’

Pharmacies in front of the general hospital which have been partially closed by the spread of MERS have encountered problems. The problems are expected to impact badly even in payment of pharmaceutical products coming...

74 products having the ‘Silent War’ in the shingles treatment market

A number of domestic pharmaceutical companies entered and competed in the shingles treatment ‘Famciclovir’ market. Since Novartis Korea introduced the product in Korea in 2001, its 73 generic products have been appro...

Interferon and ribavirin will receive benefits due to MERS

The government has unveiled the supporting method for MERS patients’ medical expenses in detail. The contents include that the National Insurance benefit will be expanded and patients-sharing expenses will be covered ...

The Forxiga complex ‘Xigduo’ is approved, having high competitiveness in the market

As the complex of the first domestic SGLT-2(Sodium-Glucose Transport Proteins) inhibitor, ‘Forxiga(dapagliflozin),’ is about to be launched, the industry has paid attention to it. According to the Ministiry of Food a...

Due to the prolonged MERS crisis, some pharmacies and wholesalers are making long faces with significantly lowered prescriptions

Since the MERS crisis seems to be prolonged, pharmacies and OTC distribution companies have been frustrated. Due to the MERS crisis which has been visualized since the late-May, one of the common opinions is that mas...

Did only pharmacies enjoyed(?) the spread of MERS?

As demand for protective masks and hand sanitizers increases due to the rapid spread of Middle East Respiratory Syndrome(MERS), shortage of goods occurred. According to the pharmaceutical distribution industry, the i...

Voluntary price reduction of generic products in the NSAID ‘celecoxib’ war

As the patent of the selective COX-2 inhibition anti-inflammatory drug ‘Celebrex(generic name: celecoxib)’ will be expired on the coming 11th of June, approximately 100 generics are expected to be poured out. Since i...

Inevitable competition between multinational and domestic pharmaceutical companies in the KRW 400 billion NSAIDs market

In the KRW 400 billion NSAIDs (non-steroidal anti-inflammatory drugs) market, the ‘2nd’ severe competition is expected among domestic and multinational pharmaceutical companies. . First and foremost, among domestic p...

The threat of the MERS spread creates confusion across the nation and busyness among pharmacies at the same time

Caused by the spread of MERS, confusion across the country has been reflected in pharmacies. According to the pharmacy field on the 3rd, consumers visiting to pharmacies have become noticeably frequent right after th...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.